Intrexon | 売上総利益





売上総利益 変化する 日付
Agenus USD 23.93M 2.79M 2025-03
Alaunos Therapeutics USD -1.13M 1.11M 2024-09
Amgen USD 6.48B 307M 2025-09
Anika Therapeutics USD 14.68M 9.46M 2025-03
Arrowhead Research USD 256.47M 228.7M 2025-09
AstraZeneca USD 12.39B 5M 2025-12
Bristol-Myers Squibb USD 8.79B 110M 2025-09
Gilead Sciences USD 6.31B 106M 2025-12
GlaxoSmithKline GBP 6.18B 106M 2025-12
Heron Therapeutics USD 23.35M 1.6M 2024-09
Incyte USD 1.39B 118.68M 2025-12
Intrexon USD -297K 167K 2024-06
Karyopharm Therapeutics USD -30.78M 1.29M 2024-12
Ligand Pharmaceuticals USD 155.28M 82.42M 2025-09
MacroGenics USD 61.25M 88.71M 2025-09
MannKind USD 2.1M 216K 2025-09
Merck USD 13.42B 431M 2025-09
Novartis USD 10.82B 695M 2025-09
Rigel Pharmaceuticals USD 28.49M 7.01M 2024-06
Roche Holding CHF 22.09B 10.04B 2025-12
Sangamo BioSciences -2.39M 1.09M 2024-06
Thermo Fisher Scientific USD 4.64B 419M 2025-12
Veracyte USD 91.28M 1.51M 2025-09
Xencor USD 21M 22.61M 2025-09


Intrexon 売上総利益 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Feb 2026.